Abstract:AIM:Previously, our group and others have demonstrated a causative relationship between severe hypertriglyceridaemia and atherogenesis in mice. Furthermore, clinical investigations have shown high levels of plasma Apolipoprotein C-III (ApoCIII) associated with hypertriglyceridaemia and even cardiovascular disease. However, it remains unclear whether ApoCIII affects restenosis in vivo, and whether such an effect is mediated by ApoCIII alone, or in combination with hypertriglyceridaemia. We sought to investigate ApoCIII in restenosis and clarify how smooth muscle cells (SMCs) respond to authentic triglyceride-rich lipoproteins (TRLs) with or without ApoCIII (TRLs ± ApoCIII).METHODS AND RESULTS:ApoCIII transgenic (ApoCIIItg) and knockout (ApoCIII-/-) mice underwent endothelial denudation to model restenosis. Here, ApoCIIItg mice displayed severe hypertriglyceridaemia and increased neointimal formation compared with wild-type (WT) or ApoCIII-/- mice. Furthermore, increased proliferating cell nuclear antigen (PCNA)-positive cells, Mac-3, and vascular cell adhesion protein-1 (VCAM-1) expression, and 4-hydroxynonenal (4HNE) production were found in lesion sites. ApoCIIItg and ApoCIII-/- mice were then crossed to low-density lipoprotein receptor-deficient (Ldlr-/-) mice and fed an atherogenic diet. ApoCIIItg/Ldlr-/- mice had significantly increased atherosclerotic lesions. However, there was no statistical difference in restenosis between ApoCIII-/- and WT mice, and in atherosclerosis between ApoCIII/Ldlr double knockout and Ldlr-/- mice. SMCs were then incubated in vitro with authentic TRLs ± ApoCIII isolated from extreme hypertriglyceridaemia glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1-deficient (GPIHBP1-/-) mice crossed with ApoCIIItg or ApoCIII-/- mice. It was shown that TRLs + ApoCIII promoted SMC proliferation, VCAM-1 expression, and reactive oxygen species (ROS) production, and activated the Akt pathway. Scavenging ROS significantly reduced SMC activation caused by TRLs + ApoCIII.CONCLUSIONS:Severe hypertriglyceridaemia resulting from ApoCIII overexpression promotes restenosis and atherosclerosis. Furthermore, we demonstrated that TRLs + ApoCIII promotes SMC proliferation.

ApoCIII Enrichment in HDL Impairs HDL-mediated Cholesterol Efflux Capacity

Relationship between apolipoprotein C-III concentrations and high-density lipoprotein subclass distribution

Apolipoproteins E and CIII interact to regulate HDL metabolism and coronary heart disease risk.

Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk

Apolipoprotein C-Iii In The High-Density Lipoprotein Proteome Of Cerebral Lacunar Infarction Patients Impairs Its Anti-Inflammatory Function

Influence of Apolipoproteincii Concentrations on Hdl Subclass Distribution

The ratio of HDL-C to apoA-I interacts with free triiodothyronine to modulate coronary artery disease risk

HDL-associated Apociii Plays an Independent Role in Predicting Postprandial Hypertriglyceridemia.

High-Sensitivity CRP is Independently Associated with HDL-Mediated Cholesterol Efflux Capacity and HDL Remodeling in Patients with Coronary Artery Disease

An Increased Plasma Level of ApoCIII-Rich Electronegative High-Density Lipoprotein May Contribute to Cognitive Impairment in Alzheimer’s Disease

Influences of apolipoprotein CII concentrations on high-density lipoprotein subclass distribution

Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice

[The Role of Apolipoprotein C3 in the Regulation of Nonalcoholic Fatty Liver Disease, Glucose and Lipid Metabolism, and Islet Β Cell Function].

APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism

Relationship Between Apolipoproteins and the Alteration of HDL Subclasses in Hyperlipidemic Subjects.

Aggravated Restenosis and Atherogenesis in ApoCIII Transgenic Mice but Lack of Protection in ApoCIII Knockouts: the Effect of Authentic Triglyceride-Rich Lipoproteins with and Without ApoCIII.

The Emerging Role of Apolipoprotein C-III: Beyond Effects on Triglyceride Metabolism

Apolipoprotein CIII Deficiency Protects Against Atherosclerosis in Knockout Rabbits

Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease

ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors

Relationship Between Apolipoprotein Concentrations and HDL Subclasses Distribution